tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Avadel Pharmaceuticals assumed with a Buy at H.C. Wainwright

H.C. Wainwright analyst Raghuram Selvaraju assumed coverage of Avadel Pharmaceuticals (AVDL) with a Buy rating and $22 price target The firm believes Avadel could exceed 4,000 narcolepsy patients on therapy by the end of next year. The company company is positioned to achieve the upper end of its guidance range this year, the analyst tells investors in a research note.

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1